Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (183)
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
21,909
Price
$108.72
Total Value
$2.38M
Shares Held After
65,292
% of Holdings
25.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
104,091
Price
$107.96
Total Value
$11.24M
Shares Held After
87,102
% of Holdings
54.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
800
Price
$110.76
Total Value
$88.61K
Shares Held After
191,292
% of Holdings
0.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
2,536
Price
$110.02
Total Value
$279.01K
Shares Held After
192,092
% of Holdings
1.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
2,373
Price
$109.10
Total Value
$258.89K
Shares Held After
194,628
% of Holdings
1.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
23,907
Price
$108.05
Total Value
$2.58M
Shares Held After
197,001
% of Holdings
10.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
10,384
Price
$107.49
Total Value
$1.12M
Shares Held After
220,908
% of Holdings
4.5%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
4,660
Price
$213.95
Total Value
$997.01K
Shares Held After
7,229
% of Holdings
39.2%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
9,292
Price
$29.34
Total Value
$272.60K
Shares Held After
67,828
% of Holdings
12.0%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
5,000
Price
$29.00
Total Value
$145.00K
Shares Held After
77,120
% of Holdings
6.1%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
55,975
Price
$18.06
Total Value
$1.01M
Shares Held After
204,940
% of Holdings
21.5%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
55,882
Price
$18.17
Total Value
$1.02M
Shares Held After
260,915
% of Holdings
17.6%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
32,739
Price
$6.86
Total Value
$224.59K
Shares Held After
465,012
% of Holdings
6.6%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
5,000
Price
$80.00
Total Value
$400.00K
Shares Held After
52,324
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
420
Price
$532.39
Total Value
$223.61K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$531.42
Total Value
$212.57K
Shares Held After
324,863
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$530.42
Total Value
$360.68K
Shares Held After
325,263
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
759
Price
$529.33
Total Value
$401.76K
Shares Held After
325,943
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
875
Price
$528.28
Total Value
$462.25K
Shares Held After
326,702
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,283
Price
$527.22
Total Value
$676.42K
Shares Held After
327,577
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,357
Price
$526.32
Total Value
$714.22K
Shares Held After
328,860
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$525.42
Total Value
$432.95K
Shares Held After
330,217
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
182
Price
$524.24
Total Value
$95.41K
Shares Held After
331,041
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$522.86
Total Value
$62.74K
Shares Held After
331,223
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
719
Price
$521.63
Total Value
$375.05K
Shares Held After
331,343
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
633
Price
$520.79
Total Value
$329.66K
Shares Held After
332,062
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$519.17
Total Value
$41.53K
Shares Held After
332,695
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$517.83
Total Value
$41.43K
Shares Held After
332,775
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$516.73
Total Value
$62.01K
Shares Held After
332,855
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
263
Price
$516.21
Total Value
$135.76K
Shares Held After
332,975
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$514.92
Total Value
$321.83K
Shares Held After
333,238
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$512.50
Total Value
$41.00K
Shares Held After
333,863
% of Holdings
0.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
18,278
Price
$129.40
Total Value
$2.37M
Shares Held After
60,486
% of Holdings
23.2%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
8,895
Price
$127.00
Total Value
$1.13M
Shares Held After
78,764
% of Holdings
10.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$522.39
Total Value
$167.17K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,308
Price
$521.50
Total Value
$682.12K
Shares Held After
45,492
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
360
Price
$518.82
Total Value
$186.78K
Shares Held After
46,800
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$517.94
Total Value
$403.99K
Shares Held After
47,160
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
5,500
Price
$134.17
Total Value
$737.93K
Shares Held After
168,498
% of Holdings
3.2%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
45,004
Price
$212.01
Total Value
$9.54M
Shares Held After
7,229
% of Holdings
86.2%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
5,849
Price
$29.00
Total Value
$169.64K
Shares Held After
67,828
% of Holdings
7.9%
Moderna, Inc. (MRNA)
Bancel Stephane — Director
Shares
187,044
Price
$58.79
Total Value
$11.00M
Shares Held After
6,187,791
% of Holdings
2.9%
Moderna, Inc. (MRNA)
Bancel Stephane — Director
Shares
39,891
Price
$58.12
Total Value
$2.32M
Shares Held After
6,374,835
% of Holdings
0.6%
Moderna, Inc. (MRNA)
Bancel Stephane — Director
Shares
124,838
Price
$56.96
Total Value
$7.11M
Shares Held After
6,414,726
% of Holdings
1.9%
Moderna, Inc. (MRNA)
Bancel Stephane — Director
Shares
147,473
Price
$56.21
Total Value
$8.29M
Shares Held After
6,539,564
% of Holdings
2.2%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
2,207
Price
$123.99
Total Value
$273.65K
Shares Held After
61,441
% of Holdings
3.5%
Showing 1–50 of 183 transactions (page 1 of 4)